1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Ibrutinib (Induction): new trials by email Literature Review of Ibrutinib (Induction) trials Research Report on Ibrutinib (Induction)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma R-CHOP/R-DHAP, Ibrutinib (Induction), ASCT conditioning - Mantle Cell Lymphoma | Phase 3 | Unknown | Prof. Dr. M. Dreyling (co-chairman) | 870 | 2016-07-01 | 2017-12-19 |
Prof. Dr. M. Dreyling (co-chairman) (1)
Denmark (1) · Germany (1) · Italy (1) · Norway (1) · Sweden (1)